Saratoga Ventures

Saratoga Ventures was a venture capital firm based in Mountain View, California, specializing in investments across various stages, including seed, early, and later stages. The firm focused on companies in the healthcare, biotechnology, pharmaceutical, and health technology sectors. Through its strategic investments, Saratoga Ventures aimed to support the growth of innovative companies within these industries.

Lee Stoian

General Partner

9 past transactions

Strategikon Pharma

Series A in 2021
Strategikon Pharma, Inc. specializes in developing software that optimizes the outsourcing processes between sponsors and providers in the pharmaceutical industry. Its flagship product, Clinical Maestro, is a unique platform designed for the comprehensive management of clinical business operations, particularly in planning, outsourcing, and budgeting clinical trials. By facilitating an integrated virtual environment, Clinical Maestro enables biopharmaceutical companies to efficiently manage complex relationships with numerous global service providers who often operate with varying processes and reporting structures. The software replaces traditional, labor-intensive methods—primarily reliant on Excel—leading to significant cost savings and enhanced operational efficiency. Case studies with major pharmaceutical firms highlight the platform's effectiveness, achieving over 80% savings compared to manual processes and over 95% accuracy in predicting clinical study budgets. Founded in 2016 and headquartered in San Rafael, California, Strategikon Pharma also offers consulting services to support new clinical business operations.

MyoScience

Series E in 2013
MyoScience Inc., founded in 2005 and based in Redwood City, California, focuses on the development and commercialization of innovative dermatological products. The company leverages advanced technology to create solutions aimed at addressing various skin-related issues. Through its efforts, MyoScience aims to provide effective products that enhance skin health and appearance.

MyoScience

Series D in 2012
MyoScience Inc., founded in 2005 and based in Redwood City, California, focuses on the development and commercialization of innovative dermatological products. The company leverages advanced technology to create solutions aimed at addressing various skin-related issues. Through its efforts, MyoScience aims to provide effective products that enhance skin health and appearance.

FRP Products

Private Equity Round in 2011
FRP Products specializes in providing surface preparation and corrosion protection services primarily for the oil, petrochemical, and pharmaceutical industries. The company offers a range of services including fiberglass lamination and repair, protective coating applications, tank-lining applications, thermal spray coating, and both factory and on-site blasting and painting. Additionally, FRP Products provides dust-free abrasive blast cleaning, pipe wrapping, and scaffolding and insulation works, ensuring comprehensive support for its clients' engineering and maintenance needs.

Tibion Bionic Technologies

Series A in 2010
Tibion Bionic Technologies is a medical device company based in Moffett Field, California, specializing in the design and development of bionic devices aimed at enhancing mobility for individuals with impairments. Founded in 2002, the company focuses on creating non-invasive technologies that support rehabilitation for those recovering from surgeries, strokes, or experiencing age-related decline in muscle function. One of its notable products, PowerKnee, is a wearable bionic device designed to aid leg rehabilitation, improve muscle strength, and assist users in daily activities. Tibion's innovations integrate advancements in orthotics, biomechanics, and control systems to provide effective solutions for mobility-impaired individuals, while actively supporting rehabilitation efforts for those with lower extremity dysfunction.

Hotspur Technologies

Series A in 2008
Hotspur Technologies is a prominent developer of catheter-based technologies designed to restore blood flow in patients with obstructed vessels. The company specializes in creating innovative products that utilize unique technology to open blood vessels more effectively and with minimal invasiveness. Through its advancements, Hotspur Technologies aims to improve patient outcomes in the treatment of vascular obstructions.

MyoScience

Series B in 2008
MyoScience Inc., founded in 2005 and based in Redwood City, California, focuses on the development and commercialization of innovative dermatological products. The company leverages advanced technology to create solutions aimed at addressing various skin-related issues. Through its efforts, MyoScience aims to provide effective products that enhance skin health and appearance.

Broncus Medical

Series F in 2006
Broncus Medical is a medical technology company specializing in the development of minimally-invasive devices for treating lung diseases, including emphysema and lung cancer. Based in Mountain View, California, with an international presence in Nyon, Switzerland, Broncus is focused on addressing significant unmet medical needs in interventional pulmonology. The company is exploring its Exhale product line, which features a patented treatment method known as Airway Bypass, aimed at providing a minimally-invasive solution for patients suffering from homogeneous emphysema. Broncus is currently conducting the pivotal EASE Trial, enrolling patients worldwide to evaluate the efficacy of this treatment in severe cases of the disease. Additionally, Broncus offers a range of innovative products designed to enhance diagnostic and therapeutic outcomes in lung care, including the Archimedes System, LungPoint, and InterVapor System.

Intact Medical

Series D in 2003
Intact Medical Corporation specializes in the design, development, and marketing of minimally invasive systems for the volumetric excision of tissue, primarily targeting diagnostic and therapeutic applications in specific cancer markets. Founded in 1998 and based in Framingham, Massachusetts, the company offers an innovative intact breast lesion excision system. This system employs a vacuum-assisted, image-guided procedure that utilizes a slender wand inserted through a small incision to extract an intact sample of suspicious breast tissue. The procedure incorporates radio frequency energy, allowing for the complete removal of identified abnormalities with minimal invasiveness. Intact Medical's mission focuses on alleviating pain, restoring health, and extending life for patients undergoing treatment.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.